These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 15622367

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N, Lanzi L, Garante CM, Tersigni F, Sergiacomi R, Petrassi M, Di Matteo A, Tufano F.
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes.
    Jaffery Z, Verma A, White CJ, Grant AG, Collins TJ, Grise MA, Jenkins JS, McMullan PW, Patel RA, Reilly JP, Thornton SN, Ramee SR.
    Catheter Cardiovasc Interv; 2012 May 01; 79(6):921-6. PubMed ID: 21542122
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study.
    Albabtain MA, Almasood A, Alshurafah H, Alamri H, Tamim H.
    J Interv Cardiol; 2013 Feb 01; 26(1):90-6. PubMed ID: 22994682
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
    Koc F, Ozdemir K, Kaya MG, Dogdu O, Vatankulu MA, Ayhan S, Erkorkmaz U, Sonmez O, Aygul MU, Kalay N, Kayrak M, Karabag T, Alihanoglu Y, Gunebakmaz O.
    Int J Cardiol; 2012 Mar 22; 155(3):418-23. PubMed ID: 21106264
    [Abstract] [Full Text] [Related]

  • 8. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].
    Vallero A, Cesano G, Pozzato M, Garbo R, Minelli M, Quarello F, Formica M.
    G Ital Nefrol; 2002 Mar 22; 19(5):529-33. PubMed ID: 12439841
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.
    Webb JG, Pate GE, Humphries KH, Buller CE, Shalansky S, Al Shamari A, Sutander A, Williams T, Fox RS, Levin A.
    Am Heart J; 2004 Sep 22; 148(3):422-9. PubMed ID: 15389228
    [Abstract] [Full Text] [Related]

  • 14. Renoprotective effect of high periprocedural doses of oral N-acetylcysteine in patients scheduled to undergo a same-day angiography.
    Balderramo DC, Verdu MB, Ramacciotti CF, Cremona LS, Lemos PA, Orías M, Eduardo M.
    Rev Fac Cien Med Univ Nac Cordoba; 2004 Sep 22; 61(2):13-9. PubMed ID: 16211988
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial.
    Carbonell N, Blasco M, Sanjuán R, Pérez-Sancho E, Sanchis J, Insa L, Bodí V, Núñez J, García-Ramón R, Miguel A.
    Int J Cardiol; 2007 Jan 31; 115(1):57-62. PubMed ID: 16814414
    [Abstract] [Full Text] [Related]

  • 17. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.
    Durham JD, Caputo C, Dokko J, Zaharakis T, Pahlavan M, Keltz J, Dutka P, Marzo K, Maesaka JK, Fishbane S.
    Kidney Int; 2002 Dec 31; 62(6):2202-7. PubMed ID: 12427146
    [Abstract] [Full Text] [Related]

  • 18. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
    Shema-Didi L, Kristal B, Eizenberg S, Marzuq N, Sussan M, Feldman-Idov Y, Ofir P, Atar S.
    Nephrology (Carlton); 2016 Apr 31; 21(4):295-300. PubMed ID: 26370061
    [Abstract] [Full Text] [Related]

  • 19. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.
    Am Heart J; 2003 Dec 31; 146(6):E23. PubMed ID: 14661012
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.